Israel’s Novocure (see here previously) announced that using its TTFields (Tumor Treating electrical Fields) technology in combination with other therapies, improved overall patient survival compared to standard therapies alone.

https://www.novocure.com/novocure-announces-pivotal-lunar-study-in-non-small-cell-lung-cancer-met-primary-overall-survival-endpoint/